Max Healthcare

Max Healthcare's Q3 profit rose 26% on higher occupancies and overseas patients, even as margins narrowed due to regulatory changes and expansion costs

The hospital operator's consolidated net profit rose 26 per cent to 3.01 billion rupees ($33.36 million), compared with 2.39 billion rupees in the year-ago period

Max Healthcare Institute, Aster DM Healthcare, and Apollo Hospitals Enterprises shares managed to end higher post Union Budget on Sunday amid weakness in markets

From parenting blame and vaccine fears to cure myths and stigma, experts explain what autism really is, and why misinformation continues to harm autistic people

On the bourses, however, Max Healthcare share price was trading 1.75 per cent lower at ₹1,044.75 per share around 11:30 AM. By comparison, BSE Sensex was trading 0.07 per cent lower at 84,637.50.

Stocks to Watch today, Dec 19: ICICI Pru AMC, HCLTech, BPCL, Airtel and RIL are among other shares that will be in focus today

This will be Max Healthcare's fourth facility in Maharashtra after the 350-bed Nanavati Max Hospital situated in Mumbai and 212-bed Alexis Hospital in Nagpur

Max Healthcare Institute Ltd on Thursday said it will invest over Rs 1,000 crore to set up a 450-bed super speciality hospital in Pune. The facility, situated in Yerawada, Pune, will mark the company's foray into the city and is expected to be commissioned over the next 3 years, Max Healthcare Institute Ltd said in a statement. The hospital will be the company's fourth facility in Western India. The company said its investment involves staggered acquisition of a 100 per cent equity stake in Yerawada Properties Pvt Ltd (YPPL), Pune and further development of the hospital over the course of next three years. "This proposed hospital will bring advanced medical care closer to patients in the region. Our entry into Pune is a strategic milestone for Max Healthcare and aligns with our long-term vision of expanding our presence in key healthcare markets across the country," Max Healthcare Institute Ltd Chairman and Managing Director, Abhay Soi said. Stating that Pune is one of India's ...

Stock is trading at 52 times its FY27 earnings estimates

Max Healthcare posted healthy Q2 performance on strong patient volumes and ARPOB, with brownfield expansion

JM Financial upgraded the stock to an 'Add' rating after the company reported a 74 per cent jump in its September quarter net profit

Max Healthcare's ₹6,000 crore plan to add 10,000 beds over four years will be fully funded through internal accruals, says CMD Abhay Soi, outlining a strategy for growth without margin dilution

Domestic brokerage firm Nuvama analysts forecast a modest sequential slowdown but a healthy ~17 per cent year-on-year (Y-o-Y) Ebitda growth, led by hospitals and diagnostics.

The Nifty50's index rebalancing will come into effect from September 30, 2025, forcing MFs and ETFs managers to buy and sell their holdings in IndusInd Bank, IndiGo, Max Health, Hero MotoCorp

Midcap stocks BSE, 360 One Wam, Max Healthcare, Crisil and Coforge look technical weak on charts, hence may dip from current levels. Here are the key levels to track on these 5 stocks.

The viral infection, marked by fever, rashes and ulcers, is spreading through classrooms and day-care centres, with experts emphasising hygiene and early recognition as key to prevention

Nuvama assigned a target price of ₹1,430 per share for Max Healthcare stock, a potential upside of 25 per cent from the previous close

IndiGo and Hero MotoCorp seem to be favourably placed on the charts; while IndusInd Bank continues to display a weak bias. Here are the key levels to track on these 4 stocks.

Meanwhile, they will offload shares worth around ₹2,500 crore and ₹2,000 crore from two-wheeler major Hero MotoCorp and IndusInd Bank on account of their removal from the 50-stock index

IndiGo and Max Healthcare are likely to see inflows of approximately $507 million and $423 million, respectively.